Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biochemistry | 2 | 2015 | 13 | 0.990 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2007 | 206 | 0.610 |
Why?
|
| Laboratories | 2 | 2015 | 35 | 0.590 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2007 | 74 | 0.550 |
Why?
|
| Molecular Biology | 1 | 2015 | 46 | 0.510 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 448 | 0.470 |
Why?
|
| Yeasts | 1 | 2013 | 19 | 0.460 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2007 | 118 | 0.350 |
Why?
|
| Students | 3 | 2020 | 519 | 0.300 |
Why?
|
| Educational Measurement | 2 | 2015 | 86 | 0.240 |
Why?
|
| Universities | 2 | 2020 | 442 | 0.230 |
Why?
|
| Glycine-tRNA Ligase | 1 | 2003 | 2 | 0.230 |
Why?
|
| Gravitation | 1 | 2002 | 7 | 0.220 |
Why?
|
| Curriculum | 2 | 2015 | 265 | 0.210 |
Why?
|
| Government Programs | 1 | 2020 | 29 | 0.190 |
Why?
|
| Cultural Diversity | 1 | 2020 | 169 | 0.170 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1207 | 0.160 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2015 | 28 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2020 | 400 | 0.130 |
Why?
|
| Comprehension | 1 | 2015 | 33 | 0.130 |
Why?
|
| Educational Technology | 1 | 2013 | 8 | 0.110 |
Why?
|
| Research Design | 1 | 2015 | 313 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 306 | 0.110 |
Why?
|
| Research | 1 | 2013 | 163 | 0.100 |
Why?
|
| Young Adult | 2 | 2020 | 4268 | 0.090 |
Why?
|
| 5' Flanking Region | 1 | 2008 | 4 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2008 | 76 | 0.080 |
Why?
|
| Weightlessness | 1 | 2007 | 16 | 0.080 |
Why?
|
| Magnetics | 1 | 2007 | 36 | 0.080 |
Why?
|
| Mycology | 1 | 2006 | 3 | 0.070 |
Why?
|
| Ribosomal Proteins | 1 | 2006 | 21 | 0.070 |
Why?
|
| Enzymes | 1 | 2006 | 32 | 0.070 |
Why?
|
| Angiotensin I | 1 | 2005 | 5 | 0.070 |
Why?
|
| Cell Division | 1 | 2006 | 307 | 0.060 |
Why?
|
| DNA | 1 | 2008 | 574 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 578 | 0.060 |
Why?
|
| Protein Binding | 2 | 2008 | 972 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2006 | 435 | 0.060 |
Why?
|
| Humans | 4 | 2020 | 37093 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2005 | 308 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2003 | 59 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2003 | 111 | 0.060 |
Why?
|
| RNA, Transfer | 1 | 2003 | 28 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 51 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2006 | 513 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 201 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 284 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 188 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 172 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 133 | 0.050 |
Why?
|
| Rotation | 1 | 2002 | 24 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 1 | 2003 | 146 | 0.050 |
Why?
|
| Plasmids | 1 | 2003 | 246 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 150 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 196 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 626 | 0.050 |
Why?
|
| Temperature | 1 | 2003 | 286 | 0.050 |
Why?
|
| Time Factors | 2 | 2004 | 1742 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2002 | 195 | 0.050 |
Why?
|
| Binding Sites | 1 | 2003 | 651 | 0.050 |
Why?
|
| RNA | 1 | 2003 | 241 | 0.050 |
Why?
|
| Male | 2 | 2020 | 20025 | 0.050 |
Why?
|
| Female | 2 | 2020 | 20969 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 88 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1039 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 515 | 0.040 |
Why?
|
| Income | 1 | 2020 | 140 | 0.040 |
Why?
|
| Educational Status | 1 | 2020 | 313 | 0.040 |
Why?
|
| Mutation | 1 | 2003 | 1095 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2020 | 1378 | 0.030 |
Why?
|
| United States | 1 | 2020 | 4223 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 5363 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 10129 | 0.020 |
Why?
|
| Yolk Sac | 1 | 2005 | 4 | 0.020 |
Why?
|
| Base Sequence | 1 | 2008 | 997 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2007 | 326 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2005 | 36 | 0.020 |
Why?
|
| Epithelium | 1 | 2005 | 79 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 142 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 2004 | 38 | 0.020 |
Why?
|
| Dehydration | 1 | 2004 | 21 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 11712 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2004 | 77 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2005 | 399 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2004 | 166 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 337 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 1198 | 0.010 |
Why?
|